Day One Biopharmaceuticals I Share Price: DAWN (Day One Biopharmaceuticals I) Stock Price Today & Updates | INDmoney

Question 1

What is Day One Biopharmaceuticals I share price today?

Accepted Answer

Day One Biopharmaceuticals I (DAWN) share price today is {{live_price}}.

Question 2

Can Indians buy Day One Biopharmaceuticals I shares?

Accepted Answer

Yes, Indians can invest in the Day One Biopharmaceuticals I (DAWN) from India.

With INDmoney, you can buy Day One Biopharmaceuticals I at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Day One Biopharmaceuticals I at zero transaction cost.

Question 3

How can I buy Day One Biopharmaceuticals I shares from India?

Accepted Answer

It is very easy to buy Day One Biopharmaceuticals I from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Day One Biopharmaceuticals I be purchased?

Accepted Answer

Yes, you can buy fractional shares of Day One Biopharmaceuticals I with INDmoney app.

Question 5

What are the documents required to start investing in Day One Biopharmaceuticals I stocks?

Accepted Answer

To start investing in Day One Biopharmaceuticals I, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Day One Biopharmaceuticals I

Accepted Answer

Today’s highest price of Day One Biopharmaceuticals I (DAWN) is {{1_rba_end}}.

Today’s lowest price of Day One Biopharmaceuticals I (DAWN) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Day One Biopharmaceuticals I

Accepted Answer

Today's market capitalisation of Day One Biopharmaceuticals I DAWN is 1.5B

Question 8

What is the 52 Week High and Low Range of Day One Biopharmaceuticals I

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Day One Biopharmaceuticals I is down from its 52 Week High?

Accepted Answer

Day One Biopharmaceuticals I (DAWN) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Day One Biopharmaceuticals I is up from its 52 Week low?

Accepted Answer

Day One Biopharmaceuticals I (DAWN) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Day One Biopharmaceuticals I?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Day One Biopharmaceuticals I

Accepted Answer

Dr. Jeremy  Bender M.B.A., Ph.D. is the current Chief Executive Officer (CEO) of Day One Biopharmaceuticals I.

Period	Day One Biopharmaceuticals I	Sector (Health Care)	Index (Russel 2000)
3 Months	0.94%	3.6%	0.0%
6 Months	-2.41%	10.2%	0.0%
1 Year	50.7%	19.6%	0.0%
3 Years	-36.93%	16.8%	-23.0%

Market Capitalization	1.5B
Book Value	$3.50
Earnings Per Share (EPS)	-1.94
Wall Street Target Price	39.38

Profit Margin	0.0%
Operating Margin TTM	-1401.45%

Return On Assets TTM	-42.22%
Return On Equity TTM	-45.71%

Revenue TTM	8.2M
Revenue Per Share TTM	0.1
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
EBITDA	-287.2M
Diluted Eps TTM	-1.94
Quarterly Earnings Growth YOY	0.0

Day One Biopharmaceuticals I (DAWN)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Vs ALNY

Vs VRTX

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-1.76
EPS Estimate Next Year	-1.86
EPS Estimate Current Quarter	-0.75
EPS Estimate Next Quarter	-0.77

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Day One Biopharmaceuticals I	5.26%	-2.41%	50.7%	-36.93%	-30.99%
Regeneron Pharmaceuticals, Inc.	-9.28%	10.06%	24.53%	74.0%	232.45%
Novo Nordisk A/s	-4.54%	-5.72%	21.59%	126.2%	349.01%
Alnylam Pharmaceuticals, Inc.	8.87%	102.98%	82.67%	44.83%	241.09%
Vertex Pharmaceuticals Incorporated	5.0%	20.77%	31.37%	158.16%	163.17%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Day One Biopharmaceuticals I	3.54	NA	NA	-1.76	-0.46	-0.42	NA	3.5
Regeneron Pharmaceuticals, Inc.	26.41	26.41	1.37	44.9	0.17	0.08	NA	261.41
Novo Nordisk A/s	40.21	40.21	1.81	3.36	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.42	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.59	0.18	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Day One Biopharmaceuticals I	Buy	$1.5B	-30.99%	3.54	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$110.0B	232.45%	26.41	32.04%
Novo Nordisk A/s	Buy	$529.8B	349.01%	40.21	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$38.1B	241.09%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$128.7B	163.17%	32.84	-4.74%

Organization	Day One Biopharmaceuticals I
Employees	169
CEO	Dr. Jeremy Bender M.B.A., Ph.D.
Industry	Healthcare